Synergistic Radiopaque System for Additive Manufacturing

Publication ID: 24-11857649_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Radiopaque System for Additive Manufacturing,” Published Technical Disclosure No. 24-11857649_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857649_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,649.

Summary of the Inventive Concept

A novel system integrating a curable radiopaque substance with AI, IoT, blockchain, and nanomaterials for enhanced radiopacity and mechanical strength in additive manufacturing applications.

Background and Problem Solved

The original patent for a curable radiopaque substance addressed the need for materials with high radiopacity in dental and medical applications. However, the patent's limitations in terms of manufacturing methods and material properties hindered its widespread adoption. The new inventive concept addresses these limitations by integrating the curable radiopaque substance with cutting-edge technologies to create a more powerful and versatile system.

Detailed Description of the Inventive Concept

The synergistic radiopaque system consists of a curable radiopaque substance according to claim 1, an AI-powered digital data model generator, a 3D printing device, and optional IoT sensors and blockchain-based tracking systems. The AI-powered generator optimizes the design of radiopaque products for maximum radiopacity, while the 3D printing device produces the products with enhanced mechanical strength. The IoT sensors enable real-time monitoring of radiopacity levels, and the blockchain-based system ensures the authenticity and traceability of the products. The system can be further enhanced by incorporating nanomaterial additives for improved radiopacity and mechanical strength.

Novelty and Inventive Step

The new claims introduce the novel combination of a curable radiopaque substance with AI, IoT, blockchain, and nanomaterials, which provides a synergistic effect in terms of enhanced radiopacity, mechanical strength, and manufacturing efficiency. The inventive step lies in the integration of these distinct technologies to create a more powerful and versatile system.

Alternative Embodiments and Variations

Alternative embodiments of the synergistic radiopaque system could include the use of different AI algorithms, IoT sensor configurations, or blockchain protocols. The system could also be adapted for use in various industries, such as aerospace or automotive, where high-radiopacity materials are required.

Potential Commercial Applications and Market

The synergistic radiopaque system has significant commercial potential in the additive manufacturing industry, particularly in dental and medical applications. The system's enhanced radiopacity and mechanical strength make it an attractive solution for producing customized implants, surgical guides, and other radiopaque products. The market for additive manufacturing in healthcare is expected to grow significantly in the coming years, providing a substantial opportunity for the commercialization of this inventive concept.

CPC Classifications

SectionClassGroup
A A61 A61K6/70
A A61 A61K6/847
A A61 A61K6/887
C C08 C08F220/12

Field of Art

Dental and medical materials engineering, focusing on polymeric compositions with radiopaque additives for additive manufacturing and medical device fabrication

Person of Ordinary Skill (PHOSITA) Profile

A materials scientist or chemical engineer with expertise in polymer chemistry, additive manufacturing techniques, and medical material formulation, possessing knowledge of radiopaque substance design and advanced manufacturing technologies

Obviousness Rationale

A PHOSITA would recognize that integrating AI, IoT, and blockchain technologies with the existing radiopaque substance represents a predictable combination of known techniques in advanced manufacturing. The core radiopaque substance remains fundamentally unchanged from the source patent, with additional technological layers that are well-established in contemporary manufacturing approaches. The proposed variations represent standard engineering problem-solving techniques for enhancing material characterization and production processes.

Obvious Combinations & Variations

Source Patent Element
Curable substance with polymerization monomers and radiopaque compounds
PTD Variation
Adding AI-powered digital model generation for optimizing product design
Obviousness Reasoning
Computational design optimization is a known technique in materials engineering, representing a predictable application of machine learning to existing material formulation processes
Source Patent Element
Radiopaque compounds for medical applications
PTD Variation
Incorporating IoT sensors for real-time radiopacity monitoring
Obviousness Reasoning
Integrating sensor technologies for material characterization is a standard approach in advanced manufacturing, providing incremental technical improvement
Source Patent Element
Polymerizable monomers with radiopaque additives
PTD Variation
Adding nanomaterial additives to enhance mechanical strength
Obviousness Reasoning
Nanomaterial enhancement of polymer properties is a well-known strategy in materials science, representing an obvious extension of existing compositional techniques
Source Patent Element
Curable radiopaque substance for medical applications
PTD Variation
Blockchain-based authentication and tracking system
Obviousness Reasoning
Implementing blockchain for product verification is a standard industry approach for ensuring material provenance and traceability
Source Patent Element
Polymerization of radiopaque substances
PTD Variation
Additive manufacturing using 3D printing technologies
Obviousness Reasoning
Applying known polymerization techniques to advanced manufacturing methods represents a predictable technological progression
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in this publication would be obvious to a person having ordinary skill in the art at the time of invention, as they represent predictable combinations of known techniques from US Patent 11857649, extending the base radiopaque substance technology through standard engineering problem-solving approaches that would be apparent to a skilled practitioner in materials science and advanced manufacturing.

Original Patent Information

Patent NumberUS 11,857,649
TitleCurable radiopaque substance
Assignee(s)Merz Dental GmbH